Researchers discover that bone marrow cancer cells diversify drastically when exiting the bone marrow, which also affects the ...

Throughout my experience with multiple myeloma, I was humbled by the unexpected support and kindness shown to me.

has developed a new biomaterial with high potential in the treatment of bone lesions or minimal residual disease in multiple myeloma patients. The findings showcase a promising approach to bone ...

The team tackled a critical challenge in treating multiple myeloma -- a blood cancer where malignant plasma cells accumulate in bone marrow, leading to debilitating bone lesions in 80% of patients.

The team tackled a critical challenge in treating multiple myeloma-a blood cancer where malignant plasma cells accumulate in bone marrow, leading to debilitating bone lesions in 80% of patients.

Multiple myeloma is a rare blood cancer that develops in the plasma cells, which are white blood cells that help you fight infection by making antibodies. Multiple myeloma starts in the plasma cells ...

Black Americans have double the risk of developing multiple myeloma compared to white Americans and are diagnosed at younger ages.

14, 2025 — A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or ... advantages of multiple myeloma cells over the different treatments ...

The following is a summary of “Time-dependent recovery of renal impairment in patients with newly diagnosed multiple myeloma, ...